Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Dec 21, 2023 11:37pm
274 Views
Post# 35797054

RE:Does anyone seen the Advertisement

RE:Does anyone seen the Advertisement
Nope. 63 treated. Goal is 100 as that is the most typical goal. They are laying this out in the most conservative fashion possible as RDW was burned in the past for seeming to promise things or build up expectations ahead of time (about a physiotherapy laser).

The real hope is that even before the enrollment is 100 that the numbers are good enough to warrant BTD, and even AA. It's about stats. If you have 100 patient the margin of error is around 10%. So you need a good enough sample size AND a good enough CR% that the stats still look good.

The other hope is that the stats look good enough to get the momentum going on JV and other things so that the timeline is not as critical to getting the share price above the current lows.
<< Previous
Bullboard Posts
Next >>